[
rdif
]
Russia to trial combined AstraZeneca, Sputnik V vaccine in Ukraine
By Reuters | Moscow
UPDATED ON JAN 03, 2021 09:02 AM IST
Russia’s sovereign RDIF announced in December trials to test a combination of the AstraZeneca vaccine with the Sputnik V shot to see if this can boost the efficacy of the British drugmaker’s vaccine.
India to make 300 million doses of Sputnik V in 2021, says Russian Direct Investment Fund chief
By hindustantimes.com | Edited by Karan Manral | Hindustan Times, New Delhi
UPDATED ON DEC 18, 2020 03:30 PM IST
The Russian Direct Investment Fund (RDIF) has partnered with Dr. Reddy’s Laboratories Limited and pharma firm Hetero for clinical trials and distribution of the Russian Covid-19 vaccine in India.
About 80% Indians surveyed want anti-Covid-19 vaccine shot: RDIF
By HT Correspondent | Edited by Zara Khan | Hindustan Times, New Delhi
UPDATED ON NOV 18, 2020 09:06 AM IST
The RDIF survey found 60% of the respondents were aware of the Russian vaccine – the highest awareness level among the countries that participated in the survey, on par with respondents from Mexico
Russia receives renewed approval for Covid-19 vaccine trials in India: RDIF
By Reuters | Posted by Jahnavi Gupta | Moscow
UPDATED ON OCT 18, 2020 04:09 PM IST
The Russian Direct Investment Fund (RDIF) and Dr Reddy’s Laboratories Ltd have received renewed approval to conduct late-stage clinical trials in India of the Russian Covid-19 vaccine.
Production hurdles hurt Russia’s Covid-19 vaccine targets
By Bloomberg | Posted by Shankhyaneel Sarkar
UPDATED ON OCT 15, 2020 12:01 PM IST
With a second wave of coronavirus cases sweeping Russia, the Kremlin needs the vaccine as it battles rising daily infection rates while seeking to avoid a repeat of a nationwide lockdown in the spring that battered the country’s economy.
Russia’s RDIF to sell 32 million Covid-19 vaccine doses to Mexico firm: Reports
By Reuters| Posted by Susmita Pakrasi | Moscow
PUBLISHED ON SEP 09, 2020 02:49 PM IST
Russia registered its first vaccine candidate, developed by Moscow’s Gamaleya Institute, in August. Late-stage trials of Sputnik-V, due to involve 40,000 participants, were launched on August 26.
